Reactive oxygen species formation by polymorphonuclear cells and mononuclear cells as a risk factor of cardiovascular diseases

Current Pharmaceutical Biotechnology

Volumn 7, Issue 2, 2006, Pages 73-80

  Yasunari, Kenichi ^a   Watanabe, Takanori ^a   Nakamura, Munehiro ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular events; Inflammation; Leukocytes; Risk factors

Indexed keywords

AMLODIPINE; BENIDIPINE; BIOLOGICAL MARKER; CARVEDILOL; DOXAZOSIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; NORADRENALIN; PITAVASTATIN; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; VALSARTAN;

ANTIOXIDANT ACTIVITY; ARTERY INTIMA; ARTERY MEDIA; BIOTECHNOLOGY; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; FLOW CYTOMETRY; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LIPID OXIDATION; MONONUCLEAR CELL; NIGHT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PREDICTION; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 33746362072     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920106776597612     Document Type: Review

References (19)

1. Ross, R. (1999) N. Engl. J. Med. 340, 115-126.
2. Smedly, L.A., Tonnesen, M.G., Sandhaus, R.A., Haslett, C.: Guthrie, L.A. Johnston, R.B. Jr., Henson, P.M. and Worthen, G.S. (1986) J. Clin. Invest. 77, 1233-1243
3. Weiss, S.J. (1989) N. Engl. J. Med. 320, 365-376.
4. Jialal I., Devaraj, S. and Kaul, N. (2001) J. Nutr. 131, 389S-394S.
5. Yasunari, K., Kohno, M., Kano, H., Yokokawa, K., Minami, M. and Yoshikawa, J. (1999) Circulation 99, 1370-1378.
6. Yasunari, K., Kohno, M., Kano, H., Minami, M. and Yoshikawa, J. (2000) Hypertension 35, 1092-1098.
7. Yasunari, K., Maeda, K., Minami M. and Yoshikawa, J. (2001) Arterioscler. Thromb. Vasc. Biol. 21, 937-942.
8. Yasunari, K., Maeda, K., Nakamura, M. and Yoshikawa, J. (2002) Hypertension 39, 433-437.
9. Yasunari, K., Maeda, K., Nakamura, M. and Yoshikawa, J. (2002) Hypertension 39, 777-780.
10. Maeda, K., Yasunari, K., Sato, E.F., Yoshikawa J. and Inoue, M. (2003) Hypertens. Res. 26, 999-1006.
11. Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T. and Yoshikawa, J. (2005) Hypetens. Res. 28, 107-112.
12. Maeda, K., Yasunari, K., Sato, E.F. and Inoue, M. (2005) Atherosclerosis 181, 87-92.
13. Watababe, T., Yasunari, K., Nakamura, N. and Maeda, K. (2006) J. Hum. Hypertens. (in press).
14. Watahabe, T., Yasunari, K. and Nakamura, N. (2006) Mini-Rev. Med. Chem. (in press).
15. Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J. and Asada A. (2004) Am. J. Med. 116, 460-465.
16. Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J. and Asada, A. (2004) J. Am. Coll. Cardilol. 43, 2116-2123.
17. Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa J. and Hirohashi K. (2005) Curr. Med. Chem. Cardiovas. Hematol. Agents 3, 61-67.
18. Yasunari, K., Matsui, T., Maeda, K., Nakamura, M. and Watanabe, T. (2006) Am. J. Hypertens. (in press).
19. Maeda, K., Yasunari, K., Watanabe, T. and Nakamura, M. (2005) Hypertens. Res. 28, 755-761.